Karlsson MO - Search Results

1

A fast method for testing covariates in population PK/PD Models.

Khandelwal A, Harling K, Jonsson EN, Hooker AC, Karlsson MO. Khandelwal A, et al. Among authors: karlsson mo. AAPS J. 2011 Sep;13(3):464-72. doi: 10.1208/s12248-011-9289-2. Epub 2011 Jul 2. AAPS J. 2011. PMID: 21725709 Free PMC article.

2

Comparison of some practical sampling strategies for population pharmacokinetic studies.

Jonsson EN, Wade JR, Karlsson MO. Jonsson EN, et al. Among authors: karlsson mo. J Pharmacokinet Biopharm. 1996 Apr;24(2):245-63. doi: 10.1007/BF02353491. J Pharmacokinet Biopharm. 1996. PMID: 8875349

3

Discrimination between rival dosing histories.

Jonsson EN, Wade JR, Almqvist G, Karlsson MO. Jonsson EN, et al. Among authors: karlsson mo. Pharm Res. 1997 Aug;14(8):984-91. doi: 10.1023/a:1012184808192. Pharm Res. 1997. PMID: 9279877 Clinical Trial.

4

Artemisinin population pharmacokinetics in children and adults with uncomplicated falciparum malaria.

Sidhu JS, Ashton M, Huong NV, Hai TN, Karlsson MO, Sy ND, Jonsson EN, Cong LD. Sidhu JS, et al. Among authors: karlsson mo. Br J Clin Pharmacol. 1998 Apr;45(4):347-54. doi: 10.1046/j.1365-2125.1998.t01-1-00686.x. Br J Clin Pharmacol. 1998. PMID: 9578181 Free PMC article.

5

Automated covariate model building within NONMEM.

Jonsson EN, Karlsson MO. Jonsson EN, et al. Among authors: karlsson mo. Pharm Res. 1998 Sep;15(9):1463-8. doi: 10.1023/a:1011970125687. Pharm Res. 1998. PMID: 9755901

6

Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.

Karlsson MO, Jonsson EN, Wiltse CG, Wade JR. Karlsson MO, et al. J Pharmacokinet Biopharm. 1998 Apr;26(2):207-46. doi: 10.1023/a:1020561807903. J Pharmacokinet Biopharm. 1998. PMID: 9795882 Clinical Trial.

7

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM.

Jonsson EN, Karlsson MO. Jonsson EN, et al. Among authors: karlsson mo. Comput Methods Programs Biomed. 1999 Jan;58(1):51-64. doi: 10.1016/s0169-2607(98)00067-4. Comput Methods Programs Biomed. 1999. PMID: 10195646

8

Likelihood-based diagnostics for influential individuals in non-linear mixed effects model selection.

Sadray S, Jonsson EN, Karlsson MO. Sadray S, et al. Among authors: karlsson mo. Pharm Res. 1999 Aug;16(8):1260-5. doi: 10.1023/a:1014857832337. Pharm Res. 1999. PMID: 10468029

9

Determination of drug effect on tumour cells, host animal toxicity and drug pharmacokinetics in a hollow-fibre model in rats.

Jonsson E, Friberg LE, Karlsson MO, Hassan SB, Freijs A, Hansen K, Larsson R. Jonsson E, et al. Among authors: karlsson mo. Cancer Chemother Pharmacol. 2000;46(6):493-500. doi: 10.1007/s002800000181. Cancer Chemother Pharmacol. 2000. PMID: 11138463

10

In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients.

Jonsson E, Friberg LE, Karlsson MO, Hassan SB, Nygren P, Kristensen J, Tholander B, Binderup L, Larsson R. Jonsson E, et al. Among authors: karlsson mo. Cancer Lett. 2001 Jan 26;162(2):193-200. doi: 10.1016/s0304-3835(00)00661-3. Cancer Lett. 2001. PMID: 11146225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters